• SenzaGen subsidiary VitroScreen secured a SEK 2.8 million order for non-animal efficacy testing from an existing customer.
• The customer is a leading global supplier of active ingredients for the health and beauty industry.
• The order follows successful assignments during 2026. Testing will begin immediately.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SenzaGen AB published the original content used to generate this news brief on November 02, 2026, and is solely responsible for the information contained therein.